Nin Guan - Oncology R&D, Astra Zeneca

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 6589: Discovery of Potent and Selective Pan-Tead Autopalmitoylation Inhibitors for the Treatment of Hippo-pathway Altered Cancers

Jacob A. Gordon, Jolanta Dubauskaite,Michelle DuPont,Nin Guan, Geoff Holdgate,Scott Mlynarski, Neil Umbreit, Danielle Sanchez, Abhishek Srivastava, Janek Suski,Nancy Su, Ryan Richards,Sabina Cosulich,Corinne Reimer,James Brownell

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Supplementary Figures 1-5 from Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors

Barry R. Davies,Nin Guan,Armelle Logie,Claire Crafter,Lyndsey Hanson,Vivien Jacobs,Neil James,Philippa Dudley,Kelly Jacques,Brendon Ladd, Celina M. D'Cruz,Michael Zinda,Justin Lindemann,Makoto Kodaira, Kenji Tamura,Emma L. Jenkins

crossref（2023）

引用0浏览0引用

Supplementary Figure legends from Tumors with AKT1<sup>E17K</sup> Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors

Barry R. Davies,Nin Guan,Armelle Logie,Claire Crafter,Lyndsey Hanson,Vivien Jacobs,Neil James,Philippa Dudley,Kelly Jacques,Brendon Ladd,Celina M. D'Cruz,Michael Zinda,Justin Lindemann,Makoto Kodaira,Kenji Tamura,Emma L. Jenkins

crossref（2023）

引用0浏览0引用

Supplementary Figure Legends from Tumors with AKT1<sup>E17K</sup> Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors

Barry R. Davies,Nin Guan,Armelle Logié,Claire Crafter,Lyndsey Hanson,Vivien N. Jacobs, M.N. James,Phillippa Dudley,Kelly Jacques,Brendon Ladd, Celina M. D’Cruz,Michael Zinda,Justin P.O. Lindemann,Makoto Kodaira, Kenji Takagi,Emma Jenkins

openalex（2023）

引用0浏览0引用

Abstract 1100: Gain and loss of function genome-wide CRISPR screens identify Hippo signaling as an important driver of resistance in EGFR mutant lung cancer

Matthias Pfeifer,Jonathan S. Brammeld,Stacey Price,Matthew Martin,Hannah Thorpe,Aurelie Bornot,Erica Banks,Nin Guan,Shanade Dunn,Maria Luisa Guerriero,Daniel O'Neill,James Pilling,Davide Gianni,James Brownell,Paul Smith,Ultan McDermott

Cancer Research（2021）

引用0浏览0引用

Abstract P066: Gain and loss of function genome-wide CRISPR screens identify Hippo signalling as an important driver of resistance in EGFR mutant lung cancer

Matthias Pfeifer,Jonathan Brammeld,Stacey Price,Matthew Martin,Hannah Thorpe,Aurelie Bornot, Ercia Banks,Nin Guan,Shanade Dunn,Maria Lisa Guerriero,Daniel O'Neill,James Pilling,Davide Gianni,James Brownell,Paul Smith,Ultan McDermott

Poster Presentations - Proffered Abstracts (2021)

引用1浏览0引用

Abstract 1100: Gain and Loss of Function Genome-Wide CRISPR Screens Identify Hippo Signaling As an Important Driver of Resistance in EGFR Mutant Lung Cancer

Matthias Pfeifer,Jonathan Brammeld,Stacey Price,Matthew J. Martin,Hannah Thorpe,Aurélie Bornot,Erica Banks,Nin Guan,Shanade Dunn,Maria Luisa Guerriero,Daniel J. O’Neill,James Pilling,Davide Gianni,James E. Brownell,Paul Smith,Ultan McDermott

Cancer researchno. 13_Supplement (2021): 1100-1100

引用0浏览0引用

Gain and loss of function genome-wide CRISPR screens identify Hippo signalling as an important driver of resistance in EGFR mutant lung cancer

CANCER RESEARCH（2021）

引用1浏览0引用

Abstract A170: Discovery of a Potent and Selective ATAD2 Inhibitor with Antiproliferative Activity in Breast Cancer Models

Meghana M. Kulkarni,Jon Winter,David Whalley,Ian Dale,Christopher Denz,Nin Guan,Deepa Bhavsar,Andrew Zhang,Timothy Rasmusson,Adrian Fretland,Sylvie M. Guichard

MOLECULAR CANCER THERAPEUTICS（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn